Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Update

Oxford Biomedica plc (OTCMKTS:OXBDF) was the recipient of a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 300 shares, a decline of 88.9% from the August 31st total of 2,700 shares. Based on an average daily trading volume, of 6,800 shares, the days-to-cover ratio is currently 0.0 days.

Oxford Biomedica Stock Performance

Shares of OXBDF stock remained flat at $5.02 during mid-day trading on Friday. The stock’s 50-day simple moving average is $4.49 and its two-hundred day simple moving average is $3.83. Oxford Biomedica has a twelve month low of $2.09 and a twelve month high of $5.02.

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.